LEF1 and aneurysmal bone cyst: Based on the results of the core signaling pathways and the discussion of protein/gene expressions [64,65], the significant biomarkers TF LEF1 and TF MYC are chosen as the drug targets for the common oncogenic mechanisms between MIBC and ABC.